Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
166 participants
INTERVENTIONAL
2015-07-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaginal Misoprostol for Cervical Ripening Prior to Endometrial Biopsy
NCT00953641
Cervical Ripening Before Endometrial Biopsy in Abnormal Uterine Bleeding Using Sublingual Misoprostol
NCT01762319
Dose Comparison of Misoprostol for Cervix Ripening Before Operative Hysteroscopy.
NCT04152317
Misoprostol Prior to Office Hysteroscopy in Patients With no Risk Factors for Experiencing Unacceptable Pain
NCT02318225
Cervical Preparation of Abortions Under Paracervical Block in the First Trimester:
NCT03043014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational approach
Wait and see
Wait and see
finishing examination without hemostatic intervention, awaiting spontaneous coagulation
Use of Monsel´s Paste
cervical coagulation using a hemostatic agents, ie monsel´s paste
Monsel´s Paste
surgical method to stop bleeding by using the hemostatic Agent monsel´s paste until no more bleeding is visible
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Monsel´s Paste
surgical method to stop bleeding by using the hemostatic Agent monsel´s paste until no more bleeding is visible
Wait and see
finishing examination without hemostatic intervention, awaiting spontaneous coagulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* first colposcopy ever
Exclusion Criteria
* bleeding disorder
* the use of blood thinner
* language barrier
* unwillingness to participate
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zydolab - Institute of Cytology and Immune Cytochemistry
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. med. Ziad Hilal
Dr. med. Ziad Hilal
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ziad Hilal, M. D.
Role: PRINCIPAL_INVESTIGATOR
Zydolab - Institute of Cytology and Immune Cytochemistry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zydolab - Institute of Cytology and Immune Cytochemistry
Dortmund, North Rhine-Westphalia, Germany
Department of Obstetrics and Gynecology of the Ruhr University Bochum
Herne, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COLPO-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.